Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MIDOSTAURIN for Malignant mast cell neoplasm: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 13 adverse event reports in the FDA FAERS database where MIDOSTAURIN was used for Malignant mast cell neoplasm.

Most Reported Side Effects for MIDOSTAURIN

Side Effect Reports % Deaths Hosp.
Death 397 13.3% 396 22
Nausea 252 8.4% 21 50
Febrile neutropenia 223 7.5% 33 90
Diarrhoea 194 6.5% 29 59
Pyrexia 188 6.3% 25 90
Acute myeloid leukaemia recurrent 171 5.7% 29 14
Pancytopenia 152 5.1% 11 25
Vomiting 152 5.1% 25 45
Drug ineffective 151 5.1% 18 13
Thrombocytopenia 140 4.7% 17 37
Neutropenia 136 4.5% 15 25
Pneumonia 128 4.3% 47 74
Bone marrow failure 109 3.6% 13 14
Sepsis 106 3.5% 54 50
Anaemia 97 3.2% 17 33

Other Indications for MIDOSTAURIN

Acute myeloid leukaemia (1,653) Product used for unknown indication (688) Systemic mastocytosis (270) Myelodysplastic syndrome (45) Mastocytic leukaemia (36) Mastocytosis (36) Leukaemia (28) Flt3 gene mutation (16) Acute leukaemia (15) Myeloid leukaemia (14)

Other Drugs Used for Malignant mast cell neoplasm

AVAPRITINIB (167) IMATINIB (10) LENALIDOMIDE (5)

Related Pages

MIDOSTAURIN Full Profile All Malignant mast cell neoplasm Drugs MIDOSTAURIN Demographics MIDOSTAURIN Timeline